Agilon Health, Inc. <AGL.N>: Truist Securities Raises Target Price to $112 From $67
AGL•Related News
Cartesian Therapeutics Q2 net income steady
RNAC•
Britain clears Paramount's $110 billion acquisition of Warner Bros.
WBD•
BioVie says Phase 2 SUNRISE-PD trial shows bezisterim improves motor and non-motor symptoms in early Parkinson’s disease
BIVI•
Cheniere Energy Partners Q2 net income more than doubles on higher LNG volumes
CQP•
BKV Corp Q2 profit beats as production gains offset weaker power prices
BKV•